CellaVision AB (LTS:0MR5) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0MR5 CellaVision AB LTS:0MR5
87 GF Score
Price kr150.00
GF Value kr192.31
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is CellaVision AB Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

LTS:0MR5
87GF Score
CellaVision AB LTS:0MR5
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CellaVision AB (LTS:0MR5) Overvalued in 2026?

Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued. The current stock price of kr150.00 is trading 22% below its estimated GF Value™ of kr192.31. GuruFocus considers CellaVision AB to be Modestly Undervalued.

Key valuation signals for LTS:0MR5:

  • Dividends Received:
  • GF Value™: kr192.31 vs. price of kr150.00 (22% below fair value)
  • GF Score™: 87/100 with 1 warning sign

No single metric tells the full story. See the LTS:0MR5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CellaVision AB Business Description

Address Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
87GF Score

Get the complete analysis for LTS:0MR5

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr150.00
Price
kr192.31
GF Value